Cargando…

Immunomodulators and Immunosuppressants for Japanese Patients with Ulcerative Colitis

Ulcerative colitis (UC) is characterized by a long-standing chronic course with remissions and exacerbations. Previously, patients do not respond to 5-aminosalicylic acid compounds and corticosteroids are considered for colectomies, however, in recent years, alternative treatments emerged for steroi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bamba, Shigeki, Tsujikawa, Tomoyuki, Sasaki, Masaya, Fujiyama, Yoshihide, Andoh, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168385/ https://www.ncbi.nlm.nih.gov/pubmed/21991497 http://dx.doi.org/10.5402/2011/194324

Ejemplares similares

Energy Expenditure in Japanese Patients with Severe or Moderate Ulcerative Colitis
por: Sasaki, Masaya, et al.
Publicado: (2010)

Energy Metabolism in Japanese Patients with Crohn’s Disease
por: Sasaki, Masaya, et al.
Publicado: (2010)

Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis
por: Nishimura, Takashi, et al.
Publicado: (2010)

Changes in energy metabolism after induction therapy in patients with severe or moderate ulcerative colitis
por: Inoue, Mai, et al.
Publicado: (2015)

Comparison of energy metabolism and nutritional status of hospitalized patients with Crohn’s disease and those with ulcerative colitis
por: Takaoka, Azusa, et al.
Publicado: (2015)

Threaded biliary inside stents are a safe and effective therapeutic option in cases of malignant hilar obstruction
por: Inatomi, Osamu, et al.
Publicado: (2013)

Serum Concentrations of Trace Elements in Patients with Crohn’s Disease Receiving Enteral Nutrition
por: Johtatsu, Tomoko, et al.
Publicado: (2007)

Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn’s disease after anti-tumor necrosis factor-α therapy
por: Nishida, Nao, et al.
Publicado: (2013)

Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
por: Yoshino, Takuya, et al.
Publicado: (2016)

Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice
por: Aomatsu, Tomoki, et al.
Publicado: (2013)

Magnified Endoscopy Combined with Narrow Band Imaging of Minimal Superficial Esophageal Neoplasia—Indicators to Differentiate Intraepithelial Neoplasias
por: Mochizuki, Yosuke, et al.
Publicado: (2012)

Prototype single-balloon enteroscopy with passive bending and high force transmission improves depth of insertion in the small intestine
por: Morita, Yasuhiro, et al.
Publicado: (2020)

Combination of vedolizumab and immunomodulators in ulcerative colitis
por: Pinton, P
Publicado: (2021)

Magnified single-balloon enteroscopy in the diagnosis of intestinal follicular lymphoma: a case series
por: Takahashi, Kenichiro, et al.
Publicado: (2018)

Characterization of gut microbiota profiles by disease activity in patients with Crohn’s disease using data mining analysis of terminal restriction fragment length polymorphisms
por: ANDOH, AKIRA, et al.
Publicado: (2014)

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
por: Ooi, Choon Jin, et al.
Publicado: (2019)

Astaxanthin, a xanthophyll carotenoid, prevents development of dextran sulphate sodium-induced murine colitis
por: Sakai, Shigeki, et al.
Publicado: (2019)

Ameliorating effects of bortezomib, a proteasome inhibitor, on development of dextran sulfate sodium-induced murine colitis
por: Sakai, Shigeki, et al.
Publicado: (2018)

Application of novel magnified single balloon enteroscopy for a patient with Cronkhite-Canada syndrome
por: Murata, Masaki, et al.
Publicado: (2017)

Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan
por: Aoki, Yasuhiro, et al.
Publicado: (2022)

Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn’s disease
por: Bamba, Shigeki, et al.
Publicado: (2017)

Development of ulcerative colitis under the immunosuppressive effect of cyclosporine
por: Passfall, J., et al.
Publicado: (1992)

Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis
por: Hashash, Jana G., et al.
Publicado: (2021)

Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis
por: Takenaka, Kazuhiro, et al.
Publicado: (2019)

Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
por: Metko, Dea, et al.
Publicado: (2023)

Low immunogenicity of vedolizumab determined by a simple drug-tolerant assay in patients with ulcerative colitis
por: Yamashita, Noriaki, et al.
Publicado: (2022)

Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study
por: Ban, Hiromitsu, et al.
Publicado: (2021)

A case of appendix adenocarcinoma associated with ulcerative colitis
por: Fukumoto, Yohsuke, et al.
Publicado: (2021)

Enterococcus durans TN-3 Induces Regulatory T Cells and Suppresses the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis
por: Kanda, Toshihiro, et al.
Publicado: (2016)

Lower-Dose and Long-Term Intermittent Interferon Therapy for Hepatitis C Genotype 2a may be a Possibility
por: Araki, Yoshio, et al.
Publicado: (2008)

Chronic cystoisosporiasis in an immunocompetent adult: A case report
por: Ohno, Masashi, et al.
Publicado: (2021)

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
por: Kobayashi, Taku, et al.
Publicado: (2019)

Severity of gastric mucosal atrophy affects the healing speed of post-endoscopic submucosal dissection ulcers
por: Otsuka, Taketo, et al.
Publicado: (2018)

Severe Colitis with Portal Venous Gas Caused by Brachyspira pilosicoli Infection
por: Chatani, Motoharu, et al.
Publicado: (2019)

Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020)

Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population
por: Andoh, Akira, et al.
Publicado: (2016)

The albumin to globulin ratio is associated with clinical outcome in Japanese patients with ulcerative colitis
por: Yagi, Sen, et al.
Publicado: (2023)

A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis
por: Tominaga, Keiichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_809uvb22uos9cou3qvpglhf8u4